[{"id":"75c79647-b107-47ed-9d39-fa812e55d7c2","acronym":"","url":"https://clinicaltrials.gov/study/NCT00082641","created_at":"2021-01-25T18:52:15.415Z","updated_at":"2024-07-02T16:35:35.972Z","phase":"Phase 1/2","brief_title":"Neoadjuvant/Adjuvant Chemotherapy, Vaccine \u0026 Adjuvant Radiation Therapy in p53-Overexpressing Stage III Breast Cancer","source_id_and_acronym":"NCT00082641","lead_sponsor":"University of Nebraska","biomarkers":" TP53","pipe":" | ","alterations":" TP53 overexpression","tags":["TP53"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TP53 overexpression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e doxorubicin hydrochloride • cyclophosphamide • INGN 225"],"overall_status":"Completed","enrollment":" Enrollment 24","initiation":"Initiation: 01/01/2004","start_date":" 01/01/2004","primary_txt":" Primary completion: 05/01/2009","primary_completion_date":" 05/01/2009","study_txt":" Completion: 01/01/2018","study_completion_date":" 01/01/2018","last_update_posted":"2023-09-22"}]